期刊文献+

甲状腺乳头状癌ACR TI-RADS分类及其转移和伴发疾病分析 被引量:3

Analysis of thyroid papillary carcinoma ACR TI-RADS classification and its metastasis and accompanying disease
下载PDF
导出
摘要 目的综合分析甲状腺乳头状癌ACRTI-RADS分类及其伴发疾病、转移情况特征,以提高超声诊断人员利用ACRTI-RADS分类对甲状腺乳头状癌与其他疾病的认识,能更好地鉴别及检出甲状腺乳头状癌。方法基于ACRTI-RADS分类回顾分析首次手术并证实甲状腺乳头状癌163例,综合分析瘤体超声特征、伴发疾病、转移情况。结果甲状腺乳头状癌发病率男:女=1:3.79;淋巴结转移男性64.70%(22/34)高于女性48.06%(62/129);癌体以实性结节占96.9%(158/163);癌体回声以低和极低回声占69.9%;直立性生长的占比73.0%;边缘光滑/模糊及不能确定的占比19.0%。出现点状强回声的癌灶占比47.2%,局灶性强回声≥3分的结节占70.6%;≥7分(TI-RADS5类)癌灶占比86.5%,发生淋巴结转移患者的TI-RADS评分12.00(10.00,14.00)高于未发生转移的患者[11.00(8.00,13.00)(P=0.003)]。病灶单发占73.6%(120/163),病灶数≥2个的占26.4%(43/163);单侧癌灶占81.6%(133/163),双侧癌灶占18.4%(30/163)。甲状腺乳头状癌伴随结节性甲状腺肿或淋巴性甲状腺炎的发生机率占74.85%(122/163),甲状腺乳头状癌伴随疾病与否与转移无统计学意义(P>0.05)。结论超声诊断应用ACRTI-RADS分类结合其伴发疾病、转移情况综合分析对甲状腺乳头状癌具有较好的检出率。 Objective To comprehensively analyze the classification of ACR TI-RADS in thyroid papillary carcinoma and the characteristicsits of its accompanying disease and metastasis,so as to improve the understanding of ultrasound clinicians using ACR TI-RADS classification for papillary thyroid carcinoma and other diseases,and to identify and detect thyroid papillary cancer better.Methods Based on the ACR TI-RADS classification,163 cases of thyroid papillary carcinoma undergoing first surgery and confirmed with papillary thyroid carcinoma were retrospectively analyzed.The tumor ultrasound characteristics,accompanying disease and metastasis were comprehensively analyzed.Results The incidence of papillary thyroid carcinoma was male:female=1:3.79;lymph node metastasis in males was 64.70%(22/34),higher than that in females(48.06%,62/129);solid nodules accounted for 96.9%(158/163)in cancer body;the low and very low echo of cancer body echoes accounted for 69.9%;upright growth of tumors accounted for 73.0%;tumors with smooth/blurred edges and undetermined edges accounted for 19.0%.The tumors with strong echoes in points accounted for 47.2%,the nodules with focal strong echoes≥3 points accounted for 70.6%;the lesions with≥7 points(TI-RADS 5)accounted for 86.5%;and the TI-RADS score of 12.00(10.00,14.00)in patients with lymph node metastasis was higher than 11.00(8.00,13.00)of patients without metastasis(P=0.003).The single lesions accounted for 73.6%(120/163),the lesions≥2 accounted for 26.4%(43/163);the unilateral cancers accounted for 81.6%(133/163),and the bilateral cancers accounted for 18.4%(30/163).The incidence of papillary thyroid carcinoma associated with nodular goiter or lymphocytic thyroiditis accounted for 74.85%(122/163),and there was no significant difference between whether the thyroid papillary carcinoma associated with disease or not and metastasis(P>0.05).Conclusion Ultrasound diagnosis ACR TI-RADS classification combined with its accompanying disease and metastasis analysis has a good detection rate for papillary thyroid carcinoma.
作者 何学森 余小琴 钟晓 涂常清 HE Xuesen;YU Xiaoqin;ZHONG Xiao;TU Changqing(Department of Ultrasound,Longgang Central Hospital in Shenzhen,Shenzhen 518116,China)
出处 《中国现代医生》 2019年第13期100-103,F0003,共5页 China Modern Doctor
基金 广东省深圳市龙岗区经济与科技发展专项资金 医疗卫生科技计划项目(LGKCYLWS2018000035)
关键词 甲状腺乳头状癌 伴发疾病 超声 ACRTI-RADS 病理学 Papillary thyroid carcinoma Accompanying disease Ultrasound ACR TI-RADS Pathology
  • 相关文献

参考文献3

二级参考文献50

  • 1彭玉兰,罗燕,张卫东,冯超,赵丽华,陈运.老年人甲状腺结节及甲状腺功能的相关性探讨[J].中华老年医学杂志,2005,24(4):290-291. 被引量:22
  • 2滕晓春,滕笛,单忠艳,关海霞,李玉姝,于晓会,范晨玲,崇巍,杨帆,何力,刘华,温松臣,戴红,毛金媛,谷晓岚,于扬,李佳,陈彦彦,赵冬,杨榕,姜雅秋,李晨阳,滕卫平.碘摄入量增加对甲状腺疾病影响的五年前瞻性流行病学研究[J].中华内分泌代谢杂志,2006,22(6):512-517. 被引量:136
  • 3托尔宾.弗拉季斯拉夫.费达罗维奇.乌克兰居民在切尔诺贝利核电站事故后的健康状况[J].解放军医学杂志,2007,32(7):761-764. 被引量:4
  • 4D'Orsi CJ, Bassett LW, Berg WA, etal. Breast imaging reporting and data system: ACR-RADS-US [M]. Reston, VA: American College of Radiology, 2003: 77-79.
  • 5Park JY, Lee HJ, Jang HW, etal. A proposal for a thyroid imaging reporting and data system for ultrasound features of thyroid carcinoma [J]. Thyroid, 2009, 19(11): 1257-1264.
  • 6Lehman C, Holt S, Peacock S, et al. Use of the american college of radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms [J]. AJR Am J Roentgenol, 2002, 179(1):15-20.
  • 7Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy [J]. J Ultrasound Med, 2004, 23(11): 1455-1464.
  • 8Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid mierocarcinoma: a surgical perspective [J]. Cancer Treat Rev, 2005, 31(6); 423-438.
  • 9Davies L, Welch HG. Increasing incidence of thyroid cancer in the united states, 1973-2002[J]. JAMA, 2006, 295(18) : 2164-2167.
  • 10Okamoto T, Yamashita T, Harasawa A, et al. Test performances of three diagnostic procedures in evaluating thyroid nodules: physical examination, ultrasonography and fine needle aspiration cytology [J].Endocr J, 1994, 41(3): 243-247.

共引文献140

同被引文献17

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部